Prescription drug · ANDA
Vasopressin NDC 25021-474
Vasopressin 20 [USP'U]/mL · Injection, Solution · Intravenous · Sagent Pharmaceuticals
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 25021-474-01 | 25021047401 | 25 VIAL in 1 CARTON (25021-474-01) / 1 mL in 1 VIALMarketed from Nov 15, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Vasopressin
- Generic name (nonproprietary)
- vasopressin
- Active ingredients
- Vasopressin — 20 [USP'U]/mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Labeler
- Sagent PharmaceuticalsNDC labeler code 25021
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 216963
- Marketing start
- Listing expires
- Other FDA classes
- Decreased Diuresis (Physiologic effect)Vasoconstriction (Physiologic effect)Vasopressins (Chemical structure)
- Identifiers
- Product ID 25021-474_c264bd5a-2111-48fc-8c43-1bd12d44006bSPL ID c264bd5a-2111-48fc-8c43-1bd12d44006bSPL set ID ad3ac280-49da-4816-9097-14517d0c0f85RxCUI 2103182UNII Y4907O6MFD
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N425021047401followed by a unit qualifier and the quantityPackage 25021-0474-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Vasopressin Injection is indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines. Vasopressin Injection is indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 25021-474
- What is NDC 25021-474?
- 25021-474 is the product NDC for Vasopressin, Vasopressin 20 [USP'U]/mL injection, solution, listed with the FDA by Sagent Pharmaceuticals. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Vasopressin.
- What is the active ingredient?
- Vasopressin.
- Who is the labeler?
- Sagent Pharmaceuticals, NDC labeler code 25021. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Vasopressin?
- 19 other product NDCs are listed under this name. See all Vasopressin NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Vasopressin products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Vasopressin | Vasopressin 20 [USP'U]/mL | Injection, SolutionIntravenous | Civica, Inc. | 72572-860 | 72572-0860-25 |
| Vasopressin | Vasopressin .4 [USP'U]/mL | InjectionIntravenous | Gland Pharma Limited | 68083-663 | 68083-0663-10 |
| vasopressin | Vasopressin, Unspecified 20 [USP'U]/mL | InjectionIntravenous | Dr. Reddy's Laboratories, Inc. | 43598-914 | 43598-0914-06 |
| Vasopressin | Vasopressin, Unspecified 20 [USP'U]/mL | InjectionIntravenous | HF Acquisition Co LLC, DBA HealthFirst | 51662-1694 | 51662-1694-02 |
| vasopressin | Vasopressin, Unspecified 20 [USP'U]/mL | InjectionIntravenous | Medical Purchasing Solutions, LLC | 71872-7334 | 71872-7334-01 |
| Vasopressin | Vasopressin 20 [USP'U]/mL | InjectionIntravenous | Gland Pharma Limited | 68083-520 | 68083-0520-1068083-0520-25 |
| Vasopressin | Vasopressin 20 [USP'U]/mL | Injection, SolutionIntravenous | American Regent, Inc. | 0517-1030 | 00517-1030-01 |
| Vasopressin | Vasopressin 20 [USP'U]/mL | Injection, SolutionIntravenous | HF Acquisition Co LLC, DBA HealthFirst | 51662-1682 | 51662-1682-02 |
| Vasopressin | Vasopressin 20 [USP'U]/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 63323-930 | 63323-0930-01 |
| Vasopressin | Vasopressin 20 [USP'U]/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 65219-039 | 65219-0039-01 |
Other NDCs under ANDA 216963
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Vasopressin | Vasopressin .4 [USP'U]/mL | InjectionIntravenous | Gland Pharma Limited | 68083-663 |
| Vasopressin | Vasopressin 20 [USP'U]/mL | InjectionIntravenous | Gland Pharma Limited | 68083-520 |